ZA200610640B - Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases - Google Patents
Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseasesInfo
- Publication number
- ZA200610640B ZA200610640B ZA200610640A ZA200610640A ZA200610640B ZA 200610640 B ZA200610640 B ZA 200610640B ZA 200610640 A ZA200610640 A ZA 200610640A ZA 200610640 A ZA200610640 A ZA 200610640A ZA 200610640 B ZA200610640 B ZA 200610640B
- Authority
- ZA
- South Africa
- Prior art keywords
- betamimetics
- treatment
- respiratory diseases
- heteroaryl compounds
- heteroaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102004045648A DE102004045648A1 (de) | 2004-09-21 | 2004-09-21 | Neue Betamimetika zur Behandlung von Atemwegserkrankungen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200610640B true ZA200610640B (en) | 2008-08-27 |
Family
ID=35355936
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200610640A ZA200610640B (en) | 2004-09-21 | 2006-12-18 | Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7429583B2 (fr) |
| EP (1) | EP1794154B1 (fr) |
| JP (1) | JP4682205B2 (fr) |
| KR (1) | KR20070060125A (fr) |
| CN (1) | CN101039937A (fr) |
| AU (1) | AU2005286521B2 (fr) |
| BR (1) | BRPI0515485A (fr) |
| CA (1) | CA2577772A1 (fr) |
| DE (1) | DE102004045648A1 (fr) |
| EA (1) | EA012727B1 (fr) |
| EC (1) | ECSP077331A (fr) |
| IL (1) | IL182010A (fr) |
| MX (1) | MX2007003031A (fr) |
| NZ (1) | NZ554579A (fr) |
| UA (1) | UA88645C2 (fr) |
| WO (1) | WO2006032627A1 (fr) |
| ZA (1) | ZA200610640B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7056916B2 (en) * | 2002-11-15 | 2006-06-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments for the treatment of chronic obstructive pulmonary disease |
| US20050272726A1 (en) * | 2004-04-22 | 2005-12-08 | Boehringer Ingelheim International Gmbh | Novel medicaments for the treatment of respiratory diseases |
| US7220742B2 (en) | 2004-05-14 | 2007-05-22 | Boehringer Ingelheim International Gmbh | Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments |
| US20050255050A1 (en) * | 2004-05-14 | 2005-11-17 | Boehringer Ingelheim International Gmbh | Powder formulations for inhalation, comprising enantiomerically pure beta agonists |
| GB0516313D0 (en) | 2005-08-08 | 2005-09-14 | Argenta Discovery Ltd | Azole derivatives and their uses |
| US7994211B2 (en) | 2005-08-08 | 2011-08-09 | Argenta Discovery Limited | Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| KR101360803B1 (ko) * | 2005-08-15 | 2014-02-11 | 베링거 인겔하임 인터내셔날 게엠베하 | 베타모방제의 제조방법 |
| EP1986644A1 (fr) * | 2006-02-16 | 2008-11-05 | Boehringer Ingelheim International GmbH | Combinaisons medicamenteuses pour le traitement de pathologies des voies respiratoires |
| PE20080142A1 (es) * | 2006-03-15 | 2008-04-14 | Boehringer Ingelheim Int | Beta-agonistas enantiomericamente puros y sus procedimientos de preparacion |
| GB0805535D0 (en) * | 2008-03-27 | 2008-04-30 | Univ Leicester | Scar prevention |
| US8236786B2 (en) | 2008-08-07 | 2012-08-07 | Pulmagen Therapeutics (Inflammation) Limited | Respiratory disease treatment |
| US8362064B2 (en) | 2008-12-30 | 2013-01-29 | Pulmagen Theraputics (Inflammation) Limited | Sulfonamide compounds for the treatment of respiratory disorders |
| WO2010150014A1 (fr) | 2009-06-24 | 2010-12-29 | Pulmagen Therapeutics (Inflammation) Limited | Glitazones 5r-5–deutérés pour le traitement de maladies respiratoires |
| GB0913342D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | Compounds - 801 |
| WO2011048409A1 (fr) | 2009-10-20 | 2011-04-28 | Astrazeneca Ab | Dérivés d'amine cyclique ayant une activité agoniste de récepteur adrénergique bêta-2 et antagoniste de récepteur muscarinique |
| GB0918922D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminopyridine derivatives |
| GB0918923D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Aminothiazole derivatives |
| GB0918924D0 (en) | 2009-10-28 | 2009-12-16 | Vantia Ltd | Azaindole derivatives |
| WO2011098746A1 (fr) | 2010-02-09 | 2011-08-18 | Pulmagen Therapeutics (Inflammation) Limited | Sels d'addition acide cristallins de l'énantiomère (5r) de la pioglitazone |
| GB201002224D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201002243D0 (en) | 2010-02-10 | 2010-03-31 | Argenta Therapeutics Ltd | Respiratory disease treatment |
| GB201009801D0 (en) | 2010-06-11 | 2010-07-21 | Astrazeneca Ab | Compounds 950 |
| JO3192B1 (ar) | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| AR099134A1 (es) * | 2014-01-24 | 2016-06-29 | Hoffmann La Roche | Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2609645A1 (de) * | 1976-03-09 | 1977-09-15 | Boehringer Sohn Ingelheim | Aminoalkylheterocyclen |
| DE2644833A1 (de) * | 1976-10-05 | 1978-04-20 | Boehringer Sohn Ingelheim | Neue 1-aryloxy-2-hydroxy-3-alkylenaminopropane und verfahren zu ihrer herstellung |
| DE2833140A1 (de) | 1978-07-28 | 1980-02-07 | Boehringer Sohn Ingelheim | Neue n-substituierte heterocyclen |
| GB8809316D0 (en) * | 1987-05-11 | 1988-05-25 | Ici America Inc | Heterocyclic ketones |
| DE10253282A1 (de) * | 2002-11-15 | 2004-05-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung |
| DE102004003428A1 (de) * | 2004-01-23 | 2005-08-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel |
-
2004
- 2004-09-21 DE DE102004045648A patent/DE102004045648A1/de not_active Withdrawn
-
2005
- 2005-09-08 US US11/222,149 patent/US7429583B2/en active Active
- 2005-09-15 KR KR1020077009109A patent/KR20070060125A/ko active IP Right Grant
- 2005-09-15 NZ NZ554579A patent/NZ554579A/en not_active IP Right Cessation
- 2005-09-15 UA UAA200703938A patent/UA88645C2/ru unknown
- 2005-09-15 JP JP2007531749A patent/JP4682205B2/ja not_active Expired - Fee Related
- 2005-09-15 BR BRPI0515485-5A patent/BRPI0515485A/pt not_active IP Right Cessation
- 2005-09-15 AU AU2005286521A patent/AU2005286521B2/en not_active Ceased
- 2005-09-15 MX MX2007003031A patent/MX2007003031A/es active IP Right Grant
- 2005-09-15 EP EP05789491A patent/EP1794154B1/fr not_active Not-in-force
- 2005-09-15 CA CA002577772A patent/CA2577772A1/fr not_active Abandoned
- 2005-09-15 CN CNA2005800352423A patent/CN101039937A/zh active Pending
- 2005-09-15 WO PCT/EP2005/054595 patent/WO2006032627A1/fr active Application Filing
- 2005-09-15 EA EA200700202A patent/EA012727B1/ru not_active IP Right Cessation
-
2006
- 2006-12-18 ZA ZA200610640A patent/ZA200610640B/xx unknown
-
2007
- 2007-03-19 IL IL182010A patent/IL182010A/en not_active IP Right Cessation
- 2007-03-21 EC EC2007007331A patent/ECSP077331A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1794154B1 (fr) | 2013-02-27 |
| US7429583B2 (en) | 2008-09-30 |
| EA200700202A1 (ru) | 2007-10-26 |
| BRPI0515485A (pt) | 2008-07-29 |
| ECSP077331A (es) | 2007-04-26 |
| IL182010A0 (en) | 2007-07-24 |
| DE102004045648A1 (de) | 2006-03-23 |
| AU2005286521A1 (en) | 2006-03-30 |
| MX2007003031A (es) | 2007-05-23 |
| IL182010A (en) | 2011-10-31 |
| EP1794154A1 (fr) | 2007-06-13 |
| US20060063817A1 (en) | 2006-03-23 |
| AU2005286521B2 (en) | 2011-11-17 |
| WO2006032627A1 (fr) | 2006-03-30 |
| JP2008513412A (ja) | 2008-05-01 |
| JP4682205B2 (ja) | 2011-05-11 |
| UA88645C2 (ru) | 2009-11-10 |
| KR20070060125A (ko) | 2007-06-12 |
| EA012727B1 (ru) | 2009-12-30 |
| CN101039937A (zh) | 2007-09-19 |
| CA2577772A1 (fr) | 2006-03-30 |
| NZ554579A (en) | 2010-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL182010A0 (en) | Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases | |
| IL277406A (en) | A new use for IL-1 beta compounds | |
| HK1199874A1 (en) | Spiro-oxindole compounds and their uses as therapeutic agents | |
| IL184934A0 (en) | 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases | |
| IL190338A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| HK1171736A1 (en) | Substituted acids for the treatment of respiratory diseases | |
| IL186615A0 (en) | Spiroheterocylic compounds and their uses as therapeutic agents | |
| ZA200701584B (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| TWI372056B (en) | Novel medicament combinations for the treatment of respiratory diseases | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| EP1962869A4 (fr) | Traitement de maladies respiratoires | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| EP1954800A4 (fr) | Composition et utilisation d'un phyto-percolate pour le traitement d'une maladie | |
| EP1928247A4 (fr) | Composition et utilisation de phyto-percolate pour le traitement d'une maladie | |
| HU0500145D0 (en) | Composition for the treatment of oral diseases | |
| EP1757282A4 (fr) | Utilisation de composes de kaurane dans l'elaboration d'un medicament | |
| GB0415181D0 (en) | Compounds for use in the treatment of infection | |
| EP1865952A4 (fr) | Compositions contenant des histamines pour le traitement des allergies | |
| PL1904060T3 (pl) | Zastosowanie pochodnych ftalocyjaniny do nie-fotodynamicznego leczenia chorób | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| IL185691A0 (en) | Novel compounds derived from 5-thioxylose and therapeutic use thereof | |
| AP2006003743A0 (en) | Compounds useful for the treatment of diseases | |
| GB0425064D0 (en) | Compounds useful for the treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases |